Novel research aims to transform radiotherapy for prostate cancer

Belfast City Hospital has become the first NHS site in the UK to use SpaceOAR hydrogel from Oncology Systems as part of a trust-sponsored clinical trial. ‘The SpaceOAR is expected to decrease side-effects experienced by men receiving radiotherapy during the trial,’ said Sharon Hynds, Lead Clinical Research Radiographer at Belfast City Hospital. ‘This innovative system works by placing a small amount of gel between the prostate and rectum, a prostate spacer, to increase the distance between them, thus reducing the radiation dose received by the rectum during treatment.
Building Better Healthcare